Financings roundup: Alma files for IPO up to $86M; Gelesis garners first-round $16M Jan. 4, 2008 By Holland Johnson
Business developments: ‘Non-strategic’ sales initiative completed by Boston Scientific Jan. 1, 2008 By Holland Johnson
RSNA notebook: Cleveland Clinic testing Riverain X-ray CAD in early lung cancer Dec. 6, 2007 By Holland Johnson
